Alzheimer's drug candidate AS-S603 begins first human safety tests
Knowledge-focused
Recruiting now
This early-phase study is testing the safety and how the body handles a new oral drug called AS-S603, which is being developed to treat Alzheimer's disease. The trial involves 88 healthy volunteers, including Korean and Caucasian adults and Korean elderly people. Participants wil…
Phase: PHASE1 • Sponsor: Amyloid Solution Inc • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC